amgen meritade glp-1 activity duration The expanding landscape of GLP-1 medicines RESULTS FROM AMGEN'S PHASE 2

Doses are typically ramped-up over several weeks to improve tolerability

Western blot analyses and immunocytochemistry staining showed PINK1 and Parkin level increased in cells treated with high glucose compared with the control group, whereas the expression of PINK1 and Parkin was abated after the treatment of liraglutide (Figures 5AD)

R.et al (2025)

Achieving good glycemic control in subjects with T2DM and HF is difficult, as several antihyperglycemic agents have been reported to increase the risk of hospitalization due to HF [43,44,45]

[DOI] [PMC free article] [PubMed] [Google Scholar] 30.Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial